How are WVE straddle max profit and max loss calculated?

Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the WVE straddle priced from the end-of-day chain at a 30-day expiry (ATM IV 102.60%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$204.23 per contract. Live intraday quotes will differ as the chain moves through the trading session.

What is the breakeven for a WVE straddle?

The breakeven for the WVE straddle priced on this page is roughly $4.95 and $9.05 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current WVE market-implied 1-standard-deviation expected move is approximately 29.41%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.

How does current WVE implied volatility affect this straddle?

WVE ATM IV is at 102.60% with IV rank near 30.64%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.

WVE Straddle Strategy

WVE (Wave Life Sciences Ltd.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional proteins, or modulate protein expression. The company also develops WVE-004, a C9orf72 molecule for the treatment of amyotrophic lateral sclerosis and frontotemporal dementia; WVE-003, a mutant huntingtin SNP3 molecule for the treatment of Huntington's disease; WVE-N531, an Exon 53 molecule for the treatment of Duchenne muscular dystrophy; and ATXN3, a discovery stage program for the treatment of spinocerebellar ataxia 3, as well as multiple preclinical programs for CNS disorders. In addition, it focuses on developing GalNAc-conjugated AIMers to treat hepatic indications comprising Alpha-1 antitrypsin deficiency (AATD); and two preclinical programs, such as Usher syndrome type 2A (USH2A) and retinitis pigmentosa due to a P23H mutation in the RHO gene (RhoP23H) for the treatment of retinal diseases. It has collaboration agreements with Pfizer Inc., Takeda Pharmaceutical Company Limited, University of Oxford, University of Massachusetts, Western Washington University, Grenoble Institute of Neurosciences, IRBM S.p.A, University of Louisville, and University College London. The company was incorporated in 2012 and is based in Singapore.

WVE (Wave Life Sciences Ltd.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $1.34B, a beta of -1.32 versus the broader market, a 52-week range of 5.02-21.73, average daily share volume of 4.5M, a public-listing history dating back to 2015, approximately 287 full-time employees. These structural characteristics shape how WVE stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of -1.32 indicates WVE has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.

What is a straddle on WVE?

A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration.

Current WVE snapshot

As of May 15, 2026, spot at $6.75, ATM IV 102.60%, IV rank 30.64%, expected move 29.41%. The straddle on WVE below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 63-day expiry.

Why this straddle structure on WVE specifically: WVE IV at 102.60% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 29.41% (roughly $1.99 on the underlying). The 63-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated WVE expiries trade a higher absolute premium for lower per-day decay. Position sizing on WVE should anchor to the underlying notional of $6.75 per share and to the trader's directional view on WVE stock.

WVE straddle setup

The WVE straddle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With WVE near $6.75, the first option leg uses a $7.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed WVE chain at a 63-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 WVE shares for the stock leg in covered calls and collars).

Action	Type	Strike / Basis	Premium (est)
Buy 1	Call	$7.00	$0.93
Buy 1	Put	$7.00	$1.13

WVE straddle risk and reward

Net Premium / Debit: -$205.00
Max Profit (per contract): Unbounded
Max Loss (per contract): -$204.23
Breakeven(s): $4.95, $9.05
Risk / Reward Ratio: Unbounded

Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit.

WVE straddle payoff curve

Modeled P&L at expiration across a range of underlying prices for the straddle on WVE. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

Underlying Price	% From Spot	P&L at Expiration
$0.01	-99.9%	+$494.00
$1.50	-77.8%	+$344.86
$2.99	-55.7%	+$195.73
$4.48	-33.6%	+$46.59
$5.98	-11.5%	-$102.54
$7.47	+10.6%	-$158.32
$8.96	+32.7%	-$9.19
$10.45	+54.8%	+$139.95
$11.94	+76.9%	+$289.09
$13.43	+99.0%	+$438.22

When traders use straddle on WVE

Straddles on WVE are pure-volatility plays that profit from large moves in either direction; traders typically buy WVE straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.

WVE thesis for this straddle

The market-implied 1-standard-deviation range for WVE extends from approximately $4.76 on the downside to $8.74 on the upside. A WVE long straddle is a pure-volatility play: it profits when the underlying moves far enough from the strike in either direction to overcome the combined call plus put debit, regardless of direction. Current WVE IV rank near 30.64% is mid-range against its 1-year distribution, so the IV signal is neutral; the straddle thesis on WVE should anchor more to the directional view and the expected-move geometry. As a Healthcare name, WVE options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to WVE-specific events.

WVE straddle positions are structurally neutral / high-volatility (long premium); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. WVE positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move WVE alongside the broader basket even when WVE-specific fundamentals are unchanged. Always rebuild the position from current WVE chain quotes before placing a trade.

Frequently asked questions

What is a straddle on WVE?: A straddle on WVE is the straddle strategy applied to WVE (stock). The strategy is structurally neutral / high-volatility (long premium): A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration. With WVE stock trading near $6.75, the strikes shown on this page are snapped to the nearest listed WVE chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are WVE straddle max profit and max loss calculated?: Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the WVE straddle priced from the end-of-day chain at a 30-day expiry (ATM IV 102.60%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$204.23 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a WVE straddle?: The breakeven for the WVE straddle priced on this page is roughly $4.95 and $9.05 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current WVE market-implied 1-standard-deviation expected move is approximately 29.41%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a straddle on WVE?: Straddles on WVE are pure-volatility plays that profit from large moves in either direction; traders typically buy WVE straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
How does current WVE implied volatility affect this straddle?: WVE ATM IV is at 102.60% with IV rank near 30.64%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.